Topics

Diseases and Illnesses
No safety concerns raised in Ebola vaccine trial, researchers say
No safety concerns raised in Ebola vaccine trial, researchers say

Initial human testing of a top Ebola vaccine candidate demonstrated that the drug was safe and provoked a strong immune response, according to researchers. In a paper published in the New England Journal of Medicine, researchers at the National Institute of Allergy and Infectious Diseases described the effects of the so-called NIAID/GSK investigational Ebola vaccine on 20 adults at the NIAID's Vaccine Research Center. "In this small study, no safety concerns were identified; however, transient fever developed within one day after vaccination in two participants," wrote study co-author Nancy Sullivan, chief of the VRC's biodefense research section, and colleagues. ...

Loading